IMAI YOICHI
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Position |
|
Article types | Original article |
Language | English |
Peer review | Peer reviewed |
Title | The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-b-mediated growth inhibition of myeloid cells. |
Journal | Formal name:Blood |
Volume, Issue, Page | 92,pp.4003-4012 |
Author and coauthor | Kurokawa M, Mitani K, Imai Y, Ogawa S, Yazaki Y, and Hirai H. |
Publication date | 1998 |